5 June 2026

Greater combined A1C reductions and weight loss with 25 mg and 50 mg versus 14 mg oral semaglutide in adults with T2D: evidence from PIONEER PLUS

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.

Keywords

Diabetes

Congress poster

GLP-1 RA

Semaglutide (oral)

PHASE 3 (RCT)